THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR ANY OTHER SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, PLEDGED OR...Warrant Agreement • December 21st, 2007 • Bioheart, Inc. • Services-commercial physical & biological research • Florida
Contract Type FiledDecember 21st, 2007 Company Industry JurisdictionThis REPRESENTATIVE’S WARRANT (this “Warrant”) of Bioheart, Inc., a Florida corporation (the “Company”), is being issued pursuant to that certain Underwriting Agreement, dated as of November [ ], 2007 (the “Underwriting Agreement”), by and between the Company and Merriman Curhan Ford & Co. and Dawson James Securities, Inc., as representatives of the underwriters named in Schedule I thereto (the “Representatives”), relating to the initial public offering (the “Offering”) of [ _] shares of common stock, $0.001 par value per share, of the Company (the “Common Stock”) underwritten by the Representatives and the underwriters named in the Underwriting Agreement.
THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR ANY OTHER SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, PLEDGED OR...Warrant Agreement • November 16th, 2007 • Bioheart, Inc. • Services-commercial physical & biological research • Florida
Contract Type FiledNovember 16th, 2007 Company Industry JurisdictionThis REPRESENTATIVE’S WARRANT (this “Warrant”) of Bioheart, Inc., a Florida corporation (the “Company”), is being issued pursuant to that certain Underwriting Agreement, dated as of November [ ], 2007 (the “Underwriting Agreement”), by and between the Company and Merriman Curhan Ford & Co. and Dawson James Securities, Inc., as representatives of the underwriters named in Schedule I thereto (the “Representatives”), relating to the initial public offering (the “Offering”) of [ _] shares of common stock, $0.001 par value per share, of the Company (the “Common Stock”) underwritten by the Representatives and the underwriters named in the Underwriting Agreement.